“Tirzepatide: Dual GIP GLP-1 Receptor Agonists, from Molecular to Clinical Practice for Treating Type-2 Diabetes and Obesity”. InaJEMD - Indonesian Journal of Endocrinology Metabolism and Diabetes, vol. 1, no. 2, Sept. 2024, pp. 96-110, https://inajemd.pbperkeni.or.id/index.php/journal/article/view/vol1-no2-section12.